神经药理学报2023,Vol.13Issue(6):45-49,5.DOI:10.3969/j.issn.2095-1396.2023.06.009
阿尔茨海默症核心生物标志物及其他生物标志物研究进展
Research Progress of Core Markers and Other Markers of Alzheimer's Disease
殷宏艳 1尤斯涵 1郭春燕1
作者信息
- 1. 河北北方学院药学院,河北省神经药理学重点实验室,张家口,075000,中国
- 折叠
摘要
Abstract
Alzheimer's disease(AD)is a neurodegenerative disease that cannot be cured until now.The main existing diagnostic methods are the detection of biomarkers in cerebrospinal fluid and positron emission tomography(PET),but their application in clinical practice is hampered due to the invasiveness and high cost of their testing.Biomarkers in blood samples can make early detection and diagnosis of ad universal because of their easy availability and low price.This article summarizes several common biomarkers of AD and their changes in AD patients,and prospects the development of ad biomarkers in the future.关键词
阿尔茨海默症/生物标志物/脑脊液/血液Key words
Alzheimer's disease/biomarkers/cerebrospinal fluid/blood分类
医药卫生引用本文复制引用
殷宏艳,尤斯涵,郭春燕..阿尔茨海默症核心生物标志物及其他生物标志物研究进展[J].神经药理学报,2023,13(6):45-49,5.